A Multi-Criteria Decision Approach for Ranking Unmet Needs in Healthcare

Access to innovative medicines for high unmet medical needs has been a concern for policy makers since many decades in view of the rapidly evolving discovering by the pharmaceutical industry of personalized treatment options and not the least in view of the escalating costs related to this. On the regulatory side, early access schemes have been developed in the EU, e.g. compassionate use programmes, accelerated assessment, conditional marketing authorization and the PRIME initiative (priority medicines) [1,2].

Source: Health Policy - July 2, 2018 Category: Health Management Authors: Irina Cleemput, Stephan Devriese, Laurence Kohn, Ren é Westhovens Source Type: research